摘要
研究了国产洛美沙星与氧氟沙星随机对照治疗细菌性感染44对(88例)的临床疗效与不良反应。洛美沙星与氧氟沙星口服剂量为200mg每日2次或400mg每日1次,疗程7~14d。治疗结束后两药临床有效率分别为93.2%(41/44)与95.5%(42/44),治疗各种致病菌所致感染的临床疗效分别为92.1%(35/38)与94.4%(34/26),细菌清除率分别为94.9%(37/39)与92.1%(35/38)。其不良反应发生率分别为6.8%(3/44)与4.5%(2/44)。上述结果经统计学比较无显著性差异。说明洛美沙星是一个安全有效的抗菌药物。
This randomized controlled clinical study observed the efficacy and safety of lomefloxacin comparied with ofloxacin in the treatment of 44 pairs (88 cases) bacterial infections. The dosage of each drug was orally given 200mg twice daily or 400mg once daily for 7 ̄14 days. After treatment, the clinical efficacy rates of lomefloxacin and ofloxacin were 93.2% (41/44) and 95.5% (42/44), the bacterial efficacy rates were 92.1% (35/38) and 94.4% (34/36), the bacterial clearance rates were 94.9% (37/39) and 92.1% (35/38), respectively. The adverse effects of both drugs were 6.8% (3/44) and 4.5% (2/44) respectively. There were no statistical differences between two drugs. The results showed that lomefolxacin was a safe and efficacious drug.
出处
《中国抗生素杂志》
CAS
CSCD
北大核心
1998年第1期51-55,共5页
Chinese Journal of Antibiotics